• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K12B filed by Gaxos.ai Inc.

    3/4/25 4:15:18 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology
    Get the next $GXAI alert in real time by email
    false --12-31 0001895618 8-K12B 0001895618 2025-03-03 2025-03-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): March 3, 2025

     

    GAXOS.AI INC.

    (Exact name of registrant as specified in its charter)

     

    Nevada   001-41620   87-3288897
    (State or other jurisdiction
    of incorporation)
      (Commission File Number)   (I. R. S. Employer
    Identification No.)

     

    101 Eisenhower Pkwy, Suite 300,

    Roseland, NJ 07068

    (Address of principal executive offices, including ZIP code)

     

    (973) 275-7428

    (Registrant’s telephone number, including area code)

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol   Name of exchange on which registered
    Common Stock, par value $0.0001   GXAI   The Nasdaq Stock Market LLC

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

    EXPLANATORY NOTE

     

    On February 28, 2025, Gaxos.ai Inc., a Delaware corporation (“Gaxos Delaware”) changed its state of incorporation from the State of Delaware to the State of Nevada (the “Reincorporation”), following the completion of the actions contemplated by the Plan of Conversion (the “Plan of Conversion”) dated February 24, 2025 of Gaxos Delaware into Gaxos.ai Inc., a Nevada corporation (the “Company”) adopted by Gaxos Delaware. Following the Reincorporation, the Company became the successor issuer to Gaxos Delaware. This Current Report on Form 8-K is being filed for the purpose of establishing the Company as the successor issuer pursuant to Rule 12g-3(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and to disclose certain related matters. Pursuant to Rule 12g-3(a) under the Exchange Act, shares of the Company’s common stock, par value $0.0001 per share, as successor issuer, are deemed registered under Section 12(b) of the Exchange Act.

     

    Item 3.03. Material Modification to Rights of Security Holders.

     

    On February 28, 2025, Gaxos Delaware filed (i) a certificate of conversion with the Secretary Gaxos Delaware of State of the State of Delaware (the “Certificate of Conversion”) and (ii) articles of conversion with the Secretary of State of the State of Nevada (“Articles of Conversion”), pursuant to which the Reincorporation became effective on March 3, 2025 (the “Effective Date”).

     

    The Reincorporation was previously submitted to a vote of, and approved at the 2024 annual meeting of stockholders (the “Annual Meeting”) of Gaxos Delaware, stockholders held on December 27, 2024.  Upon the effectiveness of the Reincorporation:

     

    ●Gaxos Delaware’s domicile changed from the State of Delaware to the State of Nevada; and

     

    ●the affairs of Gaxos Delaware ceased to be governed by the laws of the State of Delaware and Gaxos Delaware’s existing Certificate of Incorporation and By-laws, as amended, and instead became governed by the laws of the State of Nevada and the Articles of Incorporation filed with the Secretary of State of the State of Nevada (the “Nevada Charter”) and the bylaws approved by the Gaxos Delaware’s board of directors (the “Nevada Bylaws”).

     

    The Reincorporation did not result in any change in the business, jobs, management, properties, location of any of the Gaxos Delaware’s offices or facilities, number of employees, obligations, assets, liabilities, or net worth (other than as a result of the costs related to the Reincorporation). The Reincorporation did not materially affect any of Gaxos Delaware’s material contracts with any third parties, and Gaxos Delaware’s rights and obligations under those material contractual arrangements continue to be the rights and obligations of Gaxos Nevada after the Reincorporation.

     

    The Reincorporation did not result in any change in the business, jobs, management, properties, location of any of the Gaxos Delaware’s offices or facilities, number of employees, obligations, assets, liabilities, or net worth (other than as a result of the costs related to the Reincorporation). The Reincorporation did not materially affect any of Gaxos Delaware’s material contracts with any third parties, and Gaxos Delaware’s rights and obligations under those material contractual arrangements continue to be the rights and obligations of Gaxos Nevada after the Reincorporation.

     

    On the Effective Date:

     

    ●each share of common stock, $0.0001 par value per share, of Gaxos Delaware that was issued and outstanding immediately prior to the Effective Time was converted into one validly issued, fully paid and nonassessable share of common stock, $0.0001 par value per share, of Gaxos Nevada;

     

    ●each option to acquire shares of Gaxos Delaware common stock outstanding immediately prior to the Effective Time was converted into an equivalent option to acquire, upon the same terms and conditions (including the vesting schedule and exercise price per share applicable to each such option) as were in effect immediately prior to the Effective Time, the same number of shares of common stock of Gaxos Nevada; and

     

    1

     

     

    ●each warrant or other right to acquire shares of Gaxos Delaware common stock outstanding immediately prior to the Effective Time was converted into an equivalent warrant or other right to acquire, upon the same terms and conditions (including the vesting schedule and exercise price per share applicable to each such warrant or other right) as were in effect immediately prior to the Effective Time, the same number of shares of common stock of Gaxos Nevada.

     

    In addition to the foregoing, each employee benefit plan, equity incentive plan or other similar plan to which Gaxos Delaware was a party is now a plan of Gaxos Nevada, and, to the extent that any such plan provided for the issuance of Gaxos Delaware common stock, as of the Effective Time, such plan is deemed to provide for the issuance of common stock of Gaxos Nevada. Furthermore, as of the Effective Time, the members of the board of directors and the officers of Gaxos Delaware continue in their respective offices as members of the board of directors and officers of Gaxos Nevada.

     

    Gaxos Delaware will not be replacing nor will Gaxos Delaware’s stockholders be required to exchange their stock certificates for new stock certificates in connection with the Reincorporation.

     

    The common stock of Gaxos Nevada continues to be traded on The Nasdaq Capital Market under the symbol “GXAI.”

     

    Certain rights of Gaxos Delaware’s stockholders were changed as a result of the Reincorporation. A more detailed description of the Plan of Conversion, Nevada Charter, Nevada Bylaws, and the effects of the Reincorporation is set forth in the Proxy Statement under “Proposal 3: Authorization to Reincorporate the Company in the State of Nevada,” which description is incorporated herein by reference.

     

    The foregoing descriptions of the Plan of Conversion, Nevada Charter, Nevada Bylaws, Certificate of Conversion and Articles of Conversion do not purport to be complete and are qualified in their entirety by reference to the full text of the Plan of Conversion, Articles of Conversion, Certificate of Conversion, Nevada Charter and Nevada Bylaws which are filed as Exhibits 2.1, 3.1, 3.2, 3.3 and 3.4 to this Current Report on Form 8-K and is incorporated herein by reference.

     

    Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

     

    The information set forth under Item 3.03 of this Current Report on Form 8-K is incorporated herein by reference.

     

    Item 8.01. Other Events.

     

    On March 4, 2025, the Company issued a press release announcing the Reincorporation. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and incorporated herein by reference.

     

    Successor Issuer

     

    In connection with the Reincorporation and by operation of Rule 12g-3(a) promulgated under the Exchange Act, Gaxos Nevada is the successor issuer to Gaxos Delaware and has succeeded to the attributes of Gaxos Delaware as the Registrant. The common stock of Gaxos Nevada is deemed to be registered under Section 12(b) of the Exchange Act, and Gaxos Nevada is subject to the informational requirements of the Exchange Act, and the rules and regulations promulgated thereunder. Gaxos Nevada hereby reports this succession in accordance with Rule 12g-3(f) promulgated under the Exchange Act.

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits.

      

    Exhibit No.   Description
    2.1   Plan of Conversion dated February 24, 2025  
    3.1   Articles of Conversion filed with the Nevada Secretary of State on February 28, 2025
    3.2   Certificate of Conversion filed with the Delaware Secretary of State on February 28, 2025
    3.3   Articles of Incorporation of Gaxos.ai Inc, a Nevada corporation
    3.4   Bylaws of Gaxos.ai Inc, a Nevada corporation
    99.1   Press Release dated March 4, 2025
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: March 4, 2025 GAXOS.AI INC.
       
      /s/ Vadim Mats
      Vadim Mats
      Chief Executive Officer

     

    3

    Get the next $GXAI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GXAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GXAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Gaxos.ai Inc.

      SC 13G - GAXOS.AI INC. (0001895618) (Subject)

      11/14/24 3:30:50 PM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology

    $GXAI
    SEC Filings

    See more
    • SEC Form 10-Q filed by Gaxos.ai Inc.

      10-Q - GAXOS.AI INC. (0001895618) (Filer)

      5/15/25 4:30:53 PM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 10-K filed by Gaxos.ai Inc.

      10-K - GAXOS.AI INC. (0001895618) (Filer)

      3/28/25 5:27:35 PM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 8-K12B filed by Gaxos.ai Inc.

      8-K12B - GAXOS.AI INC. (0001895618) (Filer)

      3/4/25 4:15:18 PM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology

    $GXAI
    Leadership Updates

    Live Leadership Updates

    See more
    • Gaxos Health Expands Medical Advisory Board

      Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. "The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health," said Vadim Mats, CEO of Gaxos.AI. "An advisory board of experts in their respective fields will allow to create a better product and advancing our mission of creating value for shareholders." Dr. Eric Margolis, M.D.  is a Board-Ce

      4/25/24 8:45:00 AM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology

    $GXAI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Gaxos Labs Launches UnGPT.ai Setting a New Standard in Humanized AI

      Roseland, NJ, May 21, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced the official launch of UnPGT.ai, a tool that makes text created by generative artificial intelligence sound natural and human. UnGPT introduces a real-time rewriting engine designed to convert machine-generated text into authentic, human-quality content without compromising meaning or context. UnGPT uses a proprietary multi-pass transformation model that outperforms leading AI detection tools and addresses one of the industry's fastest growing concerns: the need for undetectable, high-quality output in se

      5/21/25 8:00:00 AM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology
    • Gaxos Labs Approved for Listing on Amazon Web Services (AWS) Marketplace

      Roseland, NJ , May 07, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that its product, Gaxos Labs for Game Developers and Publishers, has been officially approved for listing on Amazon Web Services (AWS) Marketplace, one of the cloud industry's largest software distribution platforms.  The approval marks a significant milestone in the Company's go-to-market strategy, enabling seamless deployment of Gaxos Labs by millions of AWS customers across 245 countries and territories. AWS Marketplace listing streamlines procurement for enterprise clients, simplifies software billi

      5/7/25 8:00:00 AM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology
    • Gaxos Health Announces Launch of AI-Powered App

      Roseland, NJ, April 08, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced the official launch of the AI-enabled Gaxos Health mobile application for iOS and Android for its customers.  The new AI-driven app is designed to personalize and optimize individual health outcomes through smart technology and science-backed routines. The Gaxos Health app leverages proprietary algorithms to deliver goal-based wellness protocols including nutrition, fitness, supplementation, and behavioral coaching. "We are thrilled to announce the launch of the Gaxos Health app," said Vadim Mats, CEO

      4/8/25 7:30:00 AM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology

    $GXAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Holzer Adam

      4 - GAXOS.AI INC. (0001895618) (Issuer)

      4/15/25 7:03:36 PM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 4 filed by Director Grayson Scott

      4 - GAXOS.AI INC. (0001895618) (Issuer)

      4/15/25 7:02:46 PM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 4 filed by Director Feldman Roman

      4 - GAXOS.AI INC. (0001895618) (Issuer)

      4/15/25 7:01:32 PM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology

    $GXAI
    Financials

    Live finance-specific insights

    See more
    • Gaxos Acquires Rights to AI-enabled Technology from Top Biohacking App

      Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it had acquired the rights to use certain AI-enabled technology from a top biohacking app, "Ultiself," in order to facilitate the development of its tech for Gaxos Health. The integration of Ultiself's proprietary technology into Gaxos Health's proposed product offering will enable enhanced customization and user experience aligning with modern-day consumer's demands for custom and efficient solutions. This move is expected to accelerate Gaxos Health's development and help solidify its positio

      3/13/24 8:30:00 AM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology